SWOG clinical trial number
SWOG-8203/04

Randomized Comparison of Adriamycin, Mitoxantrone, and Bisantrene in Patients with Metastatic Breast Cancer not Previously Exposed to Intercalating Chemotherapy

Closed
Phase
Published
Abbreviated Title
Randomized Comparison of Adriamycin, Mitoxantrone, and Bisantrene in Patients with Metastatic Breast Cancer not Previously Exposed to Intercalating Chemotherapy
Activated
12/23/1982
Closed
05/01/1986

Publication Information Expand/Collapse

1991

Randomized trial of doxorubicin, bisantrene and mitoxantrone in advanced breast cancer. A Southwest Oncology Group study.

JD Cowan;S Green;J Neidhart;S McClure;C Coltman, Jr;C Gumbart;S Martino;LF Hutchins;RL Stephens;CB Vaughan;CK Osborne JNCI 83(15):1077-1084

1987

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

FJ Mather;RM Simon;DD Von Hoff Cancer Treat Rep 71(6):

1986

Randomized trial of novantrone (N), bisantrene (B), andadriamycin (A) in advanced breast cancer.

JD Cowan;CK Osborne;JJ Costanzi;BA Neilan;JN Bickers;JA Neidhart;M Heller ASCO 5:59(#228)

1985

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer. A Southwest Oncology Group study.

JD Cowan;CK Osborne;JA Neidhart;DD Von Hoff;JJ Costanzi;CR Vaughn IND 3:149-152

The Southwest Oncology Group randomized trial of novantrone, adriamycin, and bisantrene in advanced breast cancer.

CK Osborne;JD Cowan;JA Neidhart;H Loveless;DD Von Hoff;JJ Costanzi;CB Vaughn The Current Status of Novantrone, John Wiley and Sons, 55-58